STRS Ohio’s Standard BioTools LAB Stock Holding History

STRS Ohio’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-23,000	Closed	-$170K	–	2222
2020 Q3	$170K	Sell	23,000 -28,100	-55%	-$194K	﹤0.01%	1709
2020 Q2	$204K	Buy	+51,100	New	+$178K	﹤0.01%	1633
2014 Q2	–	Sell	-11,698	Closed	-$516K	–	1726
2014 Q1	$516K	Buy	11,698 +8,098	+225%	+$356K	﹤0.01%	1150
2013 Q4	$138K	Buy	+3,600	New	+$106K	﹤0.01%	1516

Other funds holding LAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Atom Investors Austin, Texas $1.4B AUM 23.77% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ACM

Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return

STRS Ohio's LAB Position: Q4 2020 in Review

STRS Ohio sold out of Standard BioTools (LAB) in Q4 2020, closing a stake of 23,000 shares — an estimated $170K sold.

STRS Ohio first reported a position in LAB in Q4 2013 and held it in 4 quarters. The position peaked at $516K in Q1 2014. 145 funds tracked by Wall St. Rank hold LAB as of Q4 2020.

STRS Ohio reported no remaining Standard BioTools position as of Q4 2020 after selling out during the quarter.
STRS Ohio sold 23,000 Standard BioTools shares in Q4 2020, an estimated $170K.
STRS Ohio first reported a position in Standard BioTools in Q4 2013 and held it in 4 quarters.
STRS Ohio's Standard BioTools position peaked at $516K in Q1 2014.
145 funds tracked by Wall St. Rank held Standard BioTools as of Q4 2020.

Based on STRS Ohio's 13F filing for Q4 2020, filed 25 Jan 2021.